Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 9
1973 14
1974 17
1975 6
1976 11
1977 8
1978 3
1979 6
1980 6
1981 5
1982 1
1983 3
1984 4
1985 4
1986 8
1987 21
1988 19
1989 37
1990 51
1991 59
1992 79
1993 86
1994 132
1995 125
1996 208
1997 189
1998 266
1999 270
2000 359
2001 407
2002 492
2003 488
2004 564
2005 590
2006 645
2007 610
2008 595
2009 604
2010 703
2011 674
2012 609
2013 675
2014 588
2015 600
2016 546
2017 511
2018 503
2019 343
2020 22
Text availability
Article attribute
Article type
Publication date

Search Results

11,583 results
Results by year
Filters applied: . Clear all
Page 1
[Pharmacology of camptothecin and its derivatives].
Rivory LP, Robert J. Rivory LP, et al. Bull Cancer. 1995 Apr;82(4):265-85. Bull Cancer. 1995. PMID: 10846537 Review. French.
Pharmacology of camptothecin esters.
Liehr JG, Harris NJ, Mendoza J, Ahmed AE, Giovanella BC. Liehr JG, et al. Ann N Y Acad Sci. 2000;922:216-23. doi: 10.1111/j.1749-6632.2000.tb07040.x. Ann N Y Acad Sci. 2000. PMID: 11193897 Review.
Novel camptothecin derivatives.
Legarza K, Yang LX. Legarza K, et al. In Vivo. 2005 Jan-Feb;19(1):283-92. In Vivo. 2005. PMID: 15796188 Free article. Review.
Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid Tumors.
Thomas A, Redon CE, Sciuto L, Padiernos E, Ji J, Lee MJ, Yuno A, Lee S, Zhang Y, Tran L, Yutzy W, Rajan A, Guha U, Chen H, Hassan R, Alewine CC, Szabo E, Bates SE, Kinders RJ, Steinberg SM, Doroshow JH, Aladjem MI, Trepel JB, Pommier Y. Thomas A, et al. J Clin Oncol. 2018 Jun 1;36(16):1594-1602. doi: 10.1200/JCO.2017.76.6915. Epub 2017 Dec 18. J Clin Oncol. 2018. PMID: 29252124 Free PMC article. Clinical Trial.
Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon Cancer.
Liu X, Jiang J, Chan R, Ji Y, Lu J, Liao YP, Okene M, Lin J, Lin P, Chang CH, Wang X, Tang I, Zheng E, Qiu W, Wainberg ZA, Nel AE, Meng H. Liu X, et al. ACS Nano. 2019 Jan 22;13(1):38-53. doi: 10.1021/acsnano.8b06164. Epub 2018 Dec 11. ACS Nano. 2019. PMID: 30525443 Free PMC article.
Cefixime allows greater dose escalation of oral irinotecan: a phase I study in pediatric patients with refractory solid tumors.
Furman WL, Crews KR, Billups C, Wu J, Gajjar AJ, Daw NC, Patrick CC, Rodriguez-Galindo C, Stewart CF, Dome JS, Panetta JC, Houghton PJ, Santana VM. Furman WL, et al. J Clin Oncol. 2006 Feb 1;24(4):563-70. doi: 10.1200/JCO.2005.03.2847. J Clin Oncol. 2006. PMID: 16446328 Clinical Trial.
11,583 results
Jump to page
Feedback